Method Description Describes how the test is performed and provides a method-specific reference
This method is performed by enzyme-multiplied immunoassay technique (EMIT) using an Olympus analyzer. The EMIT assay is a homogeneous enzyme immunoassay technique used for the analysis of specific compounds in biological fluids. The assay is based on competition for antibody binding sites between drug in the specimen and drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6P-DH). Enzyme activity decreases upon binding to the antibody, so the drug concentration in the specimen can be measured in terms of enzyme activity. Active enzyme converts oxidized nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance change that is measured spectrophotometrically. Endogenous serum G6P-DH does not interfere because the coenzyme functions only with the bacterial enzyme employed in the assay.(Package insert: EMIT Amikacin Assay, Syva Company, Siemens Healthcare Diagnostics, Newark, DE, February 2007)
PDF Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Sunday; Varies